NCT05823376View on ClinicalTrials.gov

Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

May 4, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

February 28, 2025

Conditions
Platelet Recovery After Umbilical Cord Blood Transplantation
Interventions
DRUG

Avatrombopag

Indications for drug reduction and withdrawal: excluding blood transfusion factors, the reduction will be 20mg/d when PLT≥50×10\^9/L; Drug administration will be stopped when PLT≥100×10\^9/L.

Trial Locations (1)

230036

RECRUITING

The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei

All Listed Sponsors
lead

Anhui Provincial Hospital

OTHER_GOV